Rchr
J-GLOBAL ID:201901002920804991   Update date: Nov. 11, 2024

Itoh Takumi

Itoh Takumi
Affiliation and department:
Homepage URL  (1): https://sites.google.com/view/menekibyougan/%E3%83%9B%E3%83%BC%E3%83%A0
Research field  (5): Immunology ,  Tumor biology ,  Dermatology ,  Allergies and connective tissue disease ,  Tumor diagnostics and therapeutics
Research keywords  (6): 炎症性疾患 ,  自己免疫疾患 ,  癌免疫 ,  癌微小環境 ,  IL-26 ,  CD26
Research theme for competitive and other funds  (2):
  • 2021 - 2024 トリプルネガティブ乳癌の薬剤耐性獲得におけるIL-26の機能解明
  • 2018 - IL-26を標的とした新規癌転移制御療法の確立
Papers (15):
  • Ryo Hatano, Hayato Nakamura, Ayako Yamamoto, Haruna Otsuka, Takumi Itoh, Nao Hosokawa, Jinghui Yu, Sedigheh Ranjbar, Yuta Hasegawa, Tsutomu Sato, et al. An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus. International immunology. 2024
  • Ryo Hatano, Takumi Itoh, Haruna Otsuka, Harumi Saeki, Ayako Yamamoto, Dan Song, Yuki Shirakawa, Satoshi Iyama, Tsutomu Sato, Noriaki Iwao, et al. Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease. American Journal of Transplantation. 2022
  • Eriko Komiya, Mitsutoshi Tominaga, Ryo Hatano, Yuji Kamikubo, Sumika Toyama, Hakushun Sakairi, Kotaro Honda, Takumi Itoh, Yayoi Kamata, Munehiro Tsurumachi, et al. Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV. Journal of Allergy and Clinical Immunology. 2021. 149. 3. 1085-1096
  • Aiko Ono-Ohmachi, Satoki Yamada, Satoru Uno, Masato Tamai, Kohei Soga, Shotaro Nakamura, Nobuyuki Udagawa, Yuko Nakamichi, Masanori Koide, Yoshikazu Morita, et al. Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance. Mucosal Immunology. 2021. 14. 6. 1335-1346
  • Takumi Itoh, Ryo Hatano, Yoshiya Horimoto, Taketo Yamada, Dan Song, Haruna Otsuka, Yuki Shirakawa, Shuji Mastuoka, Noriaki Iwao, Thomas M. Aune, et al. IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells. Cell Death & Disease. 2021. 12. 6
more...
MISC (6):
more...
Patents (2):
  • 抗癌剤への抵抗性改善剤
  • 抗ヒトIL-26抗体
Books (1):
  • Advances in Medicine and Biology
    Nova Science Publishers 2018
Lectures and oral presentations  (5):
  • 「がん免疫における多機能性サイトカインの役割」
    (第19回日本免疫治療学会学術集会 2022)
  • 乾癬における新規炎症性サイトカインIL-26の役割
    (第14回TAP 乾癬とアトピー性皮膚炎の基礎と臨床を考える会 2018)
  • 乾癬における新規炎症性サイトカインIL-26の役割と分子標的療法の開発
    (第33回日本乾癬学会学術大会 2018)
  • 難治性自己免疫疾患における新規炎症性サイトカインIL-26の役割と分子標的療法の開発
    (第62回日本リウマチ学会 2018)
  • IL-26 facilitates angiogenesis and skin inflammation via inducing FGF2 production in a murine model of imiquimod-induced psoriasis
    (2017)
Education (1):
  • 2014 - 2017 Juntendo University Graduate School of Health and Sports Science.
Work history (3):
  • 2022/04 - 現在 Graduate School of Medicine, Juntendo University Department of Therapy Development and Innovation for Immune Disorders and Cancers
  • 2018/04 - 2022/03 Juntendo University Graduate School of Medicine
  • 2017/04 - 2022/03 Juntendo University Graduate School of Medicine
Awards (2):
  • 2019/08 - Janssen Psoriasis Award Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis
  • 2018/10 - 一般財団法人 日本産業科学研究所 研究助成金
Association Membership(s) (5):
日本呼吸器学会 ,  JAPANESE SOCIETY FOR PSORIASIS RESEARCH ,  THE JAPANESE CANCER ASSOCIATION ,  JAPAN COLLEGE OF RHEUMATOLOGY ,  THE JAPANESE SOCIETY FOR IMMUNOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page